Last reviewed · How we verify
Oleogel-S10, non-adhesive wound dressing — Competitive Intelligence Brief
phase 3
Wound care
Small molecule
Live · refreshed every 30 min
Target snapshot
Oleogel-S10, non-adhesive wound dressing (Oleogel-S10, non-adhesive wound dressing) — Birken AG. Oleogel-S10 acts as a non-adhesive wound dressing.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Oleogel-S10, non-adhesive wound dressing TARGET | Oleogel-S10, non-adhesive wound dressing | Birken AG | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Oleogel-S10, non-adhesive wound dressing CI watch — RSS
- Oleogel-S10, non-adhesive wound dressing CI watch — Atom
- Oleogel-S10, non-adhesive wound dressing CI watch — JSON
- Oleogel-S10, non-adhesive wound dressing alone — RSS
Cite this brief
Drug Landscape (2026). Oleogel-S10, non-adhesive wound dressing — Competitive Intelligence Brief. https://druglandscape.com/ci/oleogel-s10-non-adhesive-wound-dressing. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab